Published in AIDS Weekly, April 17th, 1995
In an invited address to the Second International Conference on Engineered Vaccines for Cancer and AIDS, held March 3-5 in San Francisco, California, Mestecky noted that monkeys that received systemic vaccines against simian immunodeficiency virus (SIV) could resist challenge with injected virus but were not protected when challenged with genital SIV infection.
Most people who acquire HIV infection are exposed via their genital mucosal membranes. And the virus does not have to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1995-04-17)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.